Knoll Pharmaceuticals Ltd (Knoll) is a 58.2% subsidiary of Abbott Laboratories, subsequent to the global takeover of Knoll AG, a pharma unit of BASF AG, Germany by Abbott Laboratories, USA. The company is a leading player in the domestic insulin, anti-diabetic, pain control and antacid market...